Clinical Trial Update: Japanese Bridging Study of Autologous Muscle Derived Cells Compared to Placebo for Female Urinary Sphincter Repair(JPN1) [Phase 3]

View source ↗

Summary

A Phase 3 Japanese bridging study evaluating autologous muscle-derived cells versus placebo for female urinary sphincter repair has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Urinary Incontinence

Drugs mentioned

• Autologous muscle-derived cells (JPN1)

Snippet

Sponsor: Cook MyoSite | Conditions: Stress Urinary Incontinence | Phase 3 | Status: WITHDRAWN